Výsledky vyhledávání - "Marta Lleonart"

Akademický článek

Costs of chronic obstructive pulmonary disease in relation to compliance with guidelines: a study in the primary care setting

Autor: Marc Miravitlles, Antoni Sicras, Carles Crespo, Maribel Cuesta, Max Brosa, Jordi Galera, Raquel Lahoz, Marta Lleonart, Maria Isabel Riera

Publikováno v: Therapeutic Advances in Respiratory Disease, Vol 7 (2013)

Background: The aim of this study was to analyse the economic impact of nonadherence to the Global Initiative for Obstructive Lung Disease (GOLD) guidelines in patients with chronic obstructive pulmonary disease (COPD). Methods: A retrospective analy

Externí odkaz: https://doaj.org/article/cf8cf5da689d426994df48abebb65fde

Zobrazit plný text záznamu

dIvergEnt: How IgE Axis Contributes to the Continuum of Allergic Asthma and Anti-IgE Therapies

Autor: Luis Prieto, Ignacio Dávila, Christian Domingo, Oscar Palomares, Antonio Nieto, Marta Lleonart, Silvia Sánchez-Ramón, Luis Pérez de Llano

Publikováno v: E-Prints Complutense. Archivo Institucional de la UCM
instname
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
International Journal of Molecular Sciences
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
E-Prints Complutense: Archivo Institucional de la UCM
Universidad Complutense de Madrid
GREDOS. Repositorio Institucional de la Universidad de Salamanca

[EN] Asthma is an airway disease characterised by chronic inflammation with intermittent or permanent symptoms including wheezing, shortness of breath, chest tightness, and cough, which vary in terms of their occurrence, frequency, and intensity. The

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d50550c2d9a9468a16b35c25683ff5c
https://eprints.ucm.es/id/eprint/66287/1/ijms-18-01328.pdf

Zobrazit plný text záznamu

Differences between physician and patient in the perception of symptoms and their severity in COPD

Autor: Jaume Ferrer, Marc Miravitlles, J. Galera, Eva Baró, Marta Lleonart

Publikováno v: Respiratory Medicine. 107:1977-1985

SummaryChronic Obstructive Pulmonary Disease (COPD) impairs quality of life and presents symptoms that affect the lives of patients. Our study analysed the degree of concordance between the patients and their pulmonologists in the perception of the s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdfecbf413a93c7cfd1e4bdca0db5e0b
https://doi.org/10.1016/j.rmed.2013.06.019

Zobrazit plný text záznamu

Costs of chronic obstructive pulmonary disease in relation to compliance with guidelines: a study in the primary care setting

Autor: Antoni Sicras, Maribel Cuesta, J. Galera, Raquel Lahoz, Max Brosa, Carles Crespo, Marc Miravitlles, Marta Lleonart, Maria Isabel Riera

Publikováno v: Therapeutic Advances in Respiratory Disease, Vol 7 (2013)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ffdef5c2a82418897bbc64c36030d4d
https://doi.org/10.1177/1753465813484080

Zobrazit plný text záznamu

Usefulness of the LCOPD, CAFS and CASIS Scales in Understanding the Impact of COPD on Patients

Autor: Miguel Barrueco, J. Galera, Elena Villarrubia, Marc Miravitlles, Marta Lleonart, Milagros Iriberri

Publikováno v: Respiration. 86:190-200

Background: The Living with COPD (LCOPD), COPD and Asthma Fatigue Scale (CAFS), and COPD and Asthma Sleep Impact Scale (CASIS) are instruments developed to assess the overall impact of chronic obstructive pulmonary disease (COPD) on daily life, fatig

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::282d65d5db181a2f2c2492ed032d50de
https://doi.org/10.1159/000341175

Zobrazit plný text záznamu

Reduced healthcare resource utilization in asthma patients treated with omalizumab in the clinical practice in Spain

Autor: Eva Martinez Moragon, Fernando Sanchez-Toril Lopez, Miguel Díaz Palacios, Marta Lleonart Dormuà, Juan Jose Liñana Santafé

Publikováno v: 5.3 Allergy and Immunology.

Introduction: In a Spanish cohort of uncontrolled patients(pts) who initiated omalizumab(OMA) in the clinical practice, symptoms and exacerbations were significantly improved. Here, we describe the concomitant change in asthma-related healthcare reso

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4d9088b0cb58035ec619070f3c54cbad
https://doi.org/10.1183/13993003.congress-2015.pa2562

Zobrazit plný text záznamu